There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Structure Therapeutics, Inc. Sponsored ADR (GPCR – Research Report), AstraZeneca (AZN – Research Report) and Biohaven Ltd. (BHVN – Research Report) with bullish sentiments.
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
In a report issued on March 18, David Risinger from Leerink Partners maintained a Buy rating on Structure Therapeutics, Inc. Sponsored ADR, with a price target of $58.00. The company’s shares closed last Wednesday at $38.63.
According to TipRanks.com, Risinger is a 5-star analyst with an average return of
Structure Therapeutics, Inc. Sponsored ADR has an analyst consensus of Strong Buy, with a price target consensus of $81.60, implying a 125.0% upside from current levels. In a report issued on March 8, BMO Capital also initiated coverage with a Buy rating on the stock with a $83.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
AstraZeneca (AZN)
In a report issued on March 19, Andrew Berens from Leerink Partners maintained a Buy rating on AstraZeneca, with a price target of $75.00. The company’s shares closed last Wednesday at $65.73.
According to TipRanks.com, Berens is a 1-star analyst with an average return of
Currently, the analyst consensus on AstraZeneca is a Moderate Buy with an average price target of $95.63, implying a 45.8% upside from current levels. In a report issued on March 13, Berenberg Bank also maintained a Buy rating on the stock with a $76.80 price target.
Biohaven Ltd. (BHVN)
Leerink Partners analyst Marc Goodman maintained a Buy rating on Biohaven Ltd. on March 18 and set a price target of $55.00. The company’s shares closed last Wednesday at $59.36, close to its 52-week high of $62.21.
According to TipRanks.com, Goodman is a 4-star analyst with an average return of
Currently, the analyst consensus on Biohaven Ltd. is a Strong Buy with an average price target of $59.11, which is a 5.5% upside from current levels. In a report issued on March 3, BTIG also maintained a Buy rating on the stock with a $59.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on GPCR:
